You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression on Osimertinib

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • CNS Progression
  • Temozolomide plus Osimertinib
  • Temozolomide plus Lorlatinib
  • Aurora, Colorado
    University of Colorado Hospital
May 12, 2022

NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • +4 more
  • (no location specified)
Oct 17, 2023

NSCLC Trial in Boston (Osimertinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Boston, Massachusetts
  • +1 more
Sep 28, 2022

Lung Cancer Trial in Seoul (Osimertinib 80 MG)

Suspended
  • Lung Cancer
  • Osimertinib 80 MG
  • Seoul, Korea, Republic of
    Samsung medical center
Jan 13, 2022

Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
May 23, 2022

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Moscow, Russian Federation
      Federal State Budgetary Institution National Medical Research Ce
    Mar 29, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New Haven, Connecticut
    • +4 more
    Jan 27, 2023

    EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic Trial in United States (Dacomitinib, Osimertinib)

    Recruiting
    • EGFR Gene Mutation
    • +2 more
    • Basking Ridge, New Jersey
    • +7 more
    Aug 27, 2021

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Duarte, California
    • +14 more
    Jan 27, 2023

    Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

    Recruiting
    • Bronchial Neoplasms
    • Cologne, Germany
    • +6 more
    Nov 2, 2022

    Non Small Cell Lung Cancer Trial in Hangzhou, Jiaxing (osimertinib mesylate tablets and anlotinib HCl capsules)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • osimertinib mesylate tablets and anlotinib hydrochloride capsules
    • Hangzhou, Zhejiang, China
    • +2 more
    Jun 17, 2020

    Combination of Osimertinib and Aspirin to Treat Osimertinib

    Unknown status
    • Non-Small Cell Lung Cancer Stage IIIB
    • +2 more
    • (no location specified)
    Jul 22, 2020

    Combination of Osimertinib and Aspirin to Treat 1st Generation

    Unknown status
    • Non-Small Cell Lung Cancer Stage IIIB
    • +2 more
    • (no location specified)
    Jul 22, 2020

    NSCLC (NSCLC) Trial in Japan, United States (Patritumab deruxtecan, Osimertinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Santa Monica, California
    • +13 more
    Feb 1, 2023

    Workup at Disease Progression and Implementation of Osimertinib

    Unknown status
    • EGFR Positive Non-small Cell Lung Cancer
      • Heidelberg, Germany
        Thoraxklinik-Heidelberg gGmbH - Universitätsklinikum Heidelberg
      Mar 9, 2020

      NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • (no location specified)
      Mar 27, 2023

      OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

      Recruiting
      • Non-small Cell Lung Cancer
        • Santiago de Compostela, Galicia, Spain
          Luis Ángel Leon Mateos
        Oct 3, 2023

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        NSCLC Trial (Cobicistat)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • (no location specified)
        Feb 17, 2023

        Lung Cancer Stage IV Trial (Osimertinib Oral Tablet)

        Not yet recruiting
        • Lung Cancer Stage IV
        • Osimertinib Oral Tablet
        • (no location specified)
        Aug 17, 2020

        NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
        • (no location specified)
        Aug 27, 2023

        Non Small Cell Lung Cancer Trial in Italy (Osimertinib)

        Recruiting
        • Non Small Cell Lung Cancer
        • Ancona, Italy
        • +10 more
        Mar 14, 2023

        Advanced NSCLC Trial in China (Gene Profile explore)

        Recruiting
        • Advanced NSCLC
        • Gene Profile explore
        • Beijing, China
        • +14 more
        Jan 27, 2023

        Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

        Recruiting
        • Carcinoma
        • La Jolla, California
        • +95 more
        Feb 1, 2023

        Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

        Not yet recruiting
        • Lung Non-Small Cell Carcinoma
        • Stage IV Lung Cancer AJCC v8
        • Biospecimen Collection
        • +5 more
        • Duarte, California
        • +1 more
        Aug 24, 2023